FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry. A method for preparing a pharmaceutical composition containing crystalline insulin AspB28 and dissolved insulin AspB28, protamine, Zn2+, an isotonic agent and a phenol compound by preparing an acid solution containing insulin AspB28, and an alkaline solution containing a substance which at physiological pH reacts as a buffer; at least one solution contains the phenol compound, mixed acid and alkaline solutions; the mixture is settled to form the pharmaceutical composition containing a phase with dissolved insulin AspB28 and a phase with crystallne insulin AspB28 to be added to the other phenol compound.
EFFECT: preparation of the pharmaceutical composition containing crystalline insulin AspB28 and dissolved insulin AspB28.
3 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOHYDRATE-CONTAINING INSULIN PREPARATIONS | 1997 |
|
RU2204411C2 |
| COMPLEX OF INSULIN ANALOG AND PROTAMINE, METHOD OF PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD OF DIABETIC TREATMENT | 1995 |
|
RU2154494C2 |
| INSULIN PREPARATION CONTAINING NACL, PARENTERAL FINISHED FORM, METHOD FOR INCREASING CHEMICAL STABILITY OF INSULIN PREPARATION | 1997 |
|
RU2182015C2 |
| COMPLEX CONTAINING HUMAN INSULIN ANALOG AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1995 |
|
RU2152399C2 |
| METHOD OF OBTAINING INSULIN ZINC COMPLEXES | 2011 |
|
RU2572214C2 |
| STABILIZED PHARMACEUTICAL COMPOSITIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | 2014 |
|
RU2702345C2 |
| INSULIN-OLIGOMER CONJUGATES, PREPARATIONS AND APPLICATIONS THEREOF | 2005 |
|
RU2527893C2 |
| INSULIN DERIVATIVES | 2004 |
|
RU2518460C2 |
| METHOD FOR PREPARING HUMAN INSULIN COMBINED PREPARATION | 2002 |
|
RU2261108C2 |
| INSULIN DERIVATIVES | 2004 |
|
RU2352581C2 |
